Comellas Alejandro P, Briva Arturo, Dada Laura A, Butti Maria L, Trejo Humberto E, Yshii Cecilia, Azzam Zaher S, Litvan Juan, Chen Jiwang, Lecuona Emilia, Pesce Liuska M, Yanagisawa Masashi, Sznajder Jacob I
Division of Pulmonary and Critical Care Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Am J Respir Crit Care Med. 2009 Jan 15;179(2):113-22. doi: 10.1164/rccm.200804-540OC. Epub 2008 Oct 23.
Endothelin-1 (ET-1) is increased in patients with high-altitude pulmonary edema and acute respiratory distress syndrome, and these patients have decreased alveolar fluid reabsorption (AFR).
To determine whether ET-1 impairs AFR via activation of endothelial cells and nitric oxide (NO) generation.
Isolated perfused rat lung, transgenic rats deficient in ETB receptors, coincubation of lung human microvascular endothelial cells (HMVEC-L) with rat alveolar epithelial type II cells or A549 cells, ouabain-sensitive 86Rb+ uptake.
The ET-1-induced decrease in AFR was prevented by blocking the endothelin receptor ETB, but not ETA. Endothelial-epithelial cell interaction is required, as direct exposure of alveolar epithelial cells (AECs) to ET-1 did not affect Na,K-ATPase function or protein abundance at the plasma membrane, whereas coincubation of HMVEC-L and AECs with ET-1 decreased Na,K-ATPase activity and protein abundance at the plasma membrane. Exposing transgenic rats deficient in ETB receptors in the pulmonary vasculature (ET-B(-/-)) to ET-1 did not decrease AFR or Na,K-ATPase protein abundance at the plasma membrane of AECs. Exposing HMVEC-L to ET-1 led to increased NO, and the ET-1-induced down-regulation of Na,K-ATPase was prevented by the NO synthase inhibitor l-NAME, but not by a guanylate cyclase inhibitor.
We provide the first evidence that ET-1, via an endothelial-epithelial interaction, leads to decreased AFR by a mechanism involving activation of endothelial ETB receptors and NO generation leading to alveolar epithelial Na,K-ATPase down-regulation in a cGMP-independent manner.
内皮素-1(ET-1)在高原肺水肿和急性呼吸窘迫综合征患者中升高,且这些患者的肺泡液体重吸收(AFR)降低。
确定ET-1是否通过激活内皮细胞和一氧化氮(NO)生成来损害AFR。
分离灌注的大鼠肺、ETB受体缺陷的转基因大鼠、人肺微血管内皮细胞(HMVEC-L)与大鼠肺泡II型上皮细胞或A549细胞共孵育、哇巴因敏感的86Rb+摄取。
通过阻断内皮素受体ETB而非ETA可防止ET-1诱导的AFR降低。内皮细胞与上皮细胞的相互作用是必需的,因为肺泡上皮细胞(AEC)直接暴露于ET-1并不影响质膜上的钠钾ATP酶功能或蛋白质丰度,而HMVEC-L与AEC与ET-1共孵育会降低质膜上的钠钾ATP酶活性和蛋白质丰度。将肺血管中缺乏ETB受体的转基因大鼠(ET-B(-/-))暴露于ET-1不会降低AFR或AEC质膜上的钠钾ATP酶蛋白质丰度。将HMVEC-L暴露于ET-1会导致NO增加,并且ET-1诱导的钠钾ATP酶下调可被NO合酶抑制剂L-NAME阻止,但不能被鸟苷酸环化酶抑制剂阻止。
我们提供了首个证据,即ET-1通过内皮细胞与上皮细胞的相互作用,以一种不依赖cGMP的机制,通过激活内皮ETB受体和生成NO导致肺泡上皮钠钾ATP酶下调,从而导致AFR降低。